Back

A panel of synapse assembly genes as a biomarker for Gliomas

2019-11-04 oncology Title + abstract only
View on medRxiv
Show abstract

Gliomas are the most common primary brain cancers. In recent years, IDH mutation and 1p/19q codeletion have been suggested as biomarkers for the diagnosis, treatment and prognosis of gliomas. However, these biomarkers are only effective for a part of glioma patients and thus more biomarkers are still emergently needed. Recently, an electrochemical communication between normal neurons and glioma cells by neuro-glioma synapse has been reported. Moreover, it was discovered that breast-to-brain meta...

Predicted journal destinations